I was just thinking about our phase 2 trial for mild to moderately ill patients, and I was wondering if it is possible for the FDA to approve Leronlimab without requiring a phase 3 trial. Based on my brief research, it appears that yes, the FDA can approve a drug without requiring a second trial. So, imo we can conceivably get two coronavirus FDA approvals in the next 4-6 weeks.